INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 289 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $246,049 | +19.6% | 8,944 | +32.6% | 0.01% | 0.0% |
Q4 2023 | $205,716 | -13.8% | 6,747 | +15.3% | 0.01% | -28.6% |
Q2 2023 | $238,726 | -6.2% | 5,854 | -14.2% | 0.01% | -22.2% |
Q1 2023 | $254,405 | -30.5% | 6,826 | +4.3% | 0.01% | -47.1% |
Q3 2022 | $366,000 | +12.6% | 6,546 | +4.4% | 0.02% | +13.3% |
Q2 2022 | $325,000 | +16.1% | 6,272 | +63.0% | 0.02% | +7.1% |
Q1 2022 | $280,000 | -4.1% | 3,848 | +55.6% | 0.01% | -17.6% |
Q4 2021 | $292,000 | -40.5% | 2,473 | -32.4% | 0.02% | -61.4% |
Q3 2021 | $491,000 | – | 3,659 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |